Brian H. Anderton

17.3k citations

195 papers · 14.5k indexed · 3 hit papers · h-index 66

Molecular Biology top 0.5%
Physiology top 0.1%
Cellular and Molecular Neuroscience top 0.2%
Cell Biology top 0.1%
Neurology top 0.2%

Co-authors: Diane P. Hanger Jean‐Pierre Brion Wendy Noble Jean‐Marc Gallo C. Hugh Reynolds P. Nigel Leigh Simon Lovestone John N. Wood
Topics: Alzheimer's disease research and treatments (82 papers)Skin and Cellular Biology Research (41 papers)Wnt/β-catenin signaling in development and cancer (28 papers)
Cited by: Physiology Neurology Cellular and Molecular Neuroscience
Journals: Nature Cell Proceedings of the National Academy of Sciences
Partner nations: United Kingdom United States Belgium

In The Last Decade

Brian H. Anderton

194 papers receiving 14.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tau phosphorylation: the therapeutic challenge for neurodegenerative disease

2009 749 citations Diane P. Hanger, Brian H. Anderton et al. profile →
Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase

1992 613 citations Diane P. Hanger, Jean‐Pierre Brion et al. Neuroscience Letters profile →
All classes of intermediate filaments share a common antigenic determinant defined by a monoclonal antibody

1981 591 citations Rebecca M. Pruss, Rhona Mirsky et al. Cell profile →

Peers

Countries citing papers authored by Brian H. Anderton

Since Specialization

Citations

This map shows the geographic impact of Brian H. Anderton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian H. Anderton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian H. Anderton more than expected).

Fields of papers citing papers by Brian H. Anderton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian H. Anderton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian H. Anderton. The network helps show where Brian H. Anderton may publish in the future.

Co-authorship network of co-authors of Brian H. Anderton

This figure shows the co-authorship network connecting the top 25 collaborators of Brian H. Anderton. A scholar is included among the top collaborators of Brian H. Anderton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian H. Anderton. Brian H. Anderton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mislocalization of neuronal tau in the absence of tangle pathology in phosphomutant tau knockin mice 2015 ·Neurobiology of Aging ·Jonathan Gilley,Kunié Ando,Anjan Seereeram,Teresa Rodríguez-Martín,Amy M. Pooler,(unknown),Brian H. Anderton,Jean‐Pierre Brion,Diane P. Hanger,Michael P. Coleman	17
2	Tyrosine 394 Is Phosphorylated in Alzheimer's Paired Helical Filament Tau and in Fetal Tau with c-Abl as the Candidate Tyrosine Kinase 2005 ·Journal of Neuroscience ·Pascal Derkinderen,Timothy M.E. Scales,Diane P. Hanger,Kit‐Yi Leung,Helen L. Byers,Malcolm Ward,Christof Lenz,Caroline Price,Ian N. Bird,Timothy Perera,Stuart Kellie,Ritchie Williamson,Wendy Noble,Richard A. Van Etten,Karelle Leroy,Jean‐Pierre Brion,C. Hugh Reynolds,Brian H. Anderton	153
3	p38α stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis 2004 ·Molecular and Cellular Neuroscience ·Steven Ackerley,Andrew J. Grierson,Steven J. Banner,Michael S. Perkinton,Janet Brownlees,Helen L. Byers,Malcolm Ward,Paul Thornhill,(unknown),Jennifer S. Waby,Brian H. Anderton,Jonathan D. Cooper,Colin Dingwall,P. Nigel Leigh,Christopher E. Shaw,Christopher C.J. Miller	92
4	Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy 2002 ·Brain ·Huw R. Morris,Graham Gibb,Regina Katzenschlager,Nicholas Wood,Diane P. Hanger,Catherine Strand,Tammaryn Lashley,S. E. Daniel,Andrew J. Lees,Brian H. Anderton,Tamás Révész	54
5	Phosphorylation Sites on Tau Identified by Nanoelectrospray Mass Spectrometry 2000 ·Journal of Neurochemistry ·C. Hugh Reynolds,Joanna Betts,Walter Blackstock,Ángel R. Nebreda,Brian H. Anderton	309
6	Induction of neuronal death by α‐synuclein 2000 ·European Journal of Neuroscience ·(unknown),Natalia Ninkina,Diane P. Hanger,Brian H. Anderton,Alun M. Davies,Vladimir L. Buchman	139
7	Molecular Cloning and Characterization of the Human Glycogen Synthase Kinase-3β Promoter 1999 ·Genomics ·Kwok‐Fai Lau,Christopher C.J. Miller,Brian H. Anderton,Pang-Chui Shaw	60
8	Cytoskeletal pathology in familial cerebral amyloid angiopathy (British type) with non-neuritic amyloid plaque formation 1999 ·Acta Neuropathologica ·Tamás Révész,Janice L. Holton,(unknown),Brian H. Anderton,F Scaravilli,Gordon T. Plant	51
9	Alzheimer's disease: Clues from flies and worms 1999 ·Current Biology ·Brian H. Anderton	39
10	New Phosphorylation Sites Identified in Hyperphosphorylated Tau (Paired Helical Filament‐Tau) from Alzheimer's Disease Brain Using Nanoelectrospray Mass Spectrometry 1998 ·Journal of Neurochemistry ·Diane P. Hanger,Joanna Betts,Thérèse Loviny,Walter Blackstock,Brian H. Anderton	323
11	Tau isoform expression and phosphorylation state during differentiation of cultured neuronal cells 1995 ·FEBS Letters ·Carthage J. Smith,Brian H. Anderton,Daniel R. Davis,Jean‐Marc Gallo	70
12	Neuroprotective effect of free radical scavengers on (BOAA)-induced neuronal damage in rat hippocampus 1994 ·Neuroscience Letters ·Colin L. Willis,Brian S. Meldrum,Peter B. Nunn,Brian H. Anderton,P. Nigel Leigh	19
13	Neurofilament Monoclonal Antibodies RT97 and 8D8 Recognize Different Modified Epitopes in Paired Helical Filament‐τ in Alzheimer's Disease 1993 ·Journal of Neurochemistry ·Jean‐Pierre Brion,(unknown),Janice Robertson,Thérèse Loviny,Brian H. Anderton	59
14	UBIQUITIN-IMMUNOREACTIVE INTRANEURONAL INCLUSIONS IN AMYOTROPHIC LATERAL SCLEROSIS 1991 ·Brain ·P. Nigel Leigh,Helen Whitwell,O. Garofalo,(unknown),Michael Swash,JE Martin,Jean‐Marc Gallo,Roy O. Weller,Brian H. Anderton	270
15	Microdissection: A novel method for the study of intracellular inclusion bodies 1990 ·The Journal of Pathology ·Joanne E. Martin,Michael Swash,(unknown),O. Garofalo,Glenn E. Dale,P. Nigel Leigh,Brian H. Anderton	1
16	Cyclic AMP-dependent expression of the heavy neurofilament (NF-H) polypeptide in differentiating neuroblastoma cells 1990 ·Molecular Brain Research ·Kieran C. Breen,Brian H. Anderton	10
17	Phosphate‐Dependent Monoclonal Antibodies to Neurofilaments and Alzheimer Neurofibrillary Tangles Recognize a Synthetic Phosphopeptide 1990 ·Journal of Neurochemistry ·Michael P. Coleman,Brian H. Anderton	37
18	Perikaryal neurofilament phosphorylation in axotomized and 6-OH-dopamine-lesioned CNS neurons 1990 ·Brain Research ·Paul Klosen,Brian H. Anderton,Jean‐Pierre Brion,Ph. van den Bosch de Aguilar	23
19	All classes of intermediate filaments share a common antigenic determinant defined by a monoclonal antibodybreakdown → 1981 ·Cell ·Rebecca M. Pruss,Rhona Mirsky,Martin Raff,Robin Thorpe,Alan J. Dowding,Brian H. Anderton	591
20	ATP‐analogue‐bound gel matrix and its use as an affinity adsorbent for Na⁺, K⁺‐atpase 1973 ·FEBS Letters ·Brian H. Anderton,(unknown),H. Fasold,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	17

About Brian H. Anderton

Brian H. Anderton is a scholar working on Cell Biology, Physiology and Cellular and Molecular Neuroscience, having authored 195 papers that have together received 14.5k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (82 papers), Skin and Cellular Biology Research (41 papers) and Wnt/β-catenin signaling in development and cancer (28 papers). The work is most often cited by research in Physiology (7.0k citations), Neurology (1.9k citations) and Cellular and Molecular Neuroscience (4.0k citations). Brian H. Anderton has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Diane P. Hanger, Jean‐Pierre Brion, Wendy Noble, Jean‐Marc Gallo, C. Hugh Reynolds, P. Nigel Leigh, Simon Lovestone, John N. Wood, Christopher C.J. Miller and James R. Woodgett. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact